Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activity Investigatorsort descending Unit Sponsor Date
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants with Previously Treated Locally Advanced/Metastatic or Surgically Unresectable.. Contract $171,440.00 Clinical Trial Aaron Scott Cancer Center Division Incyte Corporation 05/2020
Phase II Pilot Study of FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-Type, Left-Sided Colorectal Cancer Contract $127,173.74 Clinical Trial Aaron Scott Cancer Center Division Academic Gastrointestinal Cancer Consortium 03/2020
A Phase 2a, Multicenter, Open-Label Study of DKN-01 in Combination with Tislelizumab +/- Chemotherapy as First-Line or Second-Line Therapy in Adult Patients with Inoperable, Locally Advanced or Metas Contract $404,272.70 Clinical Trial Aaron Scott Cancer Center Division Leap Therapeutics, Inc. 10/2020
A Phase 3, Randomized, Open-label Study to Evaluate the Safety and Efficacy of Pembrolizumab + Lenvatinib + Chemotherapy Induction Therapy Followed by Pembrolizumab + Lenvatinib Compared with… Contract $500.00 Clinical Trial Aaron Scott Cancer Center Division Merck Sharp & Dohme Corp. 02/2021
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator Phase 2/3 study of Tucatinib in Combination with Trastuzumab, Ramucirumab, and Paclitaxel in Subjects with Previously Treated, Locally Contract $453,804.20 Clinical Trial Aaron Scott Cancer Center Division Seagen Inc. 01/2021
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects with Heart Failure with Reduced Ejection Fraction... Contract $105,851.40 Clinical Trial Aaron Wolfson Sarver Heart Center Cytokinetics, Incorporated 09/2020
A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Enzastaurin Plus R-CHOP Versus R-CHOP in Treatment-Naive Subjects with High-Risk Diffuse Large B-Cell Lymphoma Who Possess the Novel.. Contract $327,830.00 Clinical Trial Abhijeet Kumar Cancer Center Division Covance, Incorporated 01/2020
A Phase II Trial of PET-Directed Therapy using AVD (Doxorubicin, Vinblastine, and Dacarbazine) Plus Brentuximab Vedotin Induction Chemotherapy, with or without Brentuximab Vedotin Plus Nivolumab, Foll Contract $40,100.00 Clinical Trial Abhijeet Kumar Cancer Center Division Mayo Foundation for Medical Education and Research (Mayo Clinic) 06/2020
Accuracy of Arthroscopic vs. Open Reduction of Ankle Syndesmosis Injuries Contract $5,000.00 Research Training Aditya Manoharan Orthopaedic Surgery Orthopaedic Research and Education Foundation 04/2020
A Randomized Controlled Trial to Improve Mother-Infant Synchrony Among Women with Childhood Adversity Grant $2,437,784.00 Research Aleeca Bell College of Nursing National Institute of Nursing Research 09/2020
A First-in-Human Phase 1b Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATRC-101 in Adults with Advanced Solid Malignancies Contract $468,451.00 Clinical Trial Alejandro Recio Boiles Cancer Center Division Atreca, Inc. 10/2020
A Novel Approach to Help Women of Reproductive Age Quit Smoking Grant $100,000.00 Research Alicia Allen Family and Community Medicine Prevent Cancer Foundation 04/2020
Hormonal Response to Infant Caregiving: A Novel Strategy to Break the Opioid Relapse Cycle During The Postpartum Period Grant $2,302,500.00 Research Alicia Allen Family and Community Medicine Eunice Kennedy Shriver National Institute of Child Health and Human Development 09/2020
Arizona Anesthesia Solutions Professional Agreement Contract $499,200.00 Other Sponsored Activity Allen Prettyman College of Nursing Arizona Anesthesia Solutions 08/2020
COVID-19's Impact on Insurance Coverage and Cancer Treatment Grant $40,000.00 Research Amanda Arrington Surgery Society for Surgery of the Alimentary Tract 09/2020
Validation of Spinal Neurotensin Receptor 2 as an Analgesic Target Grant $1,539,731.00 Research Amol Patwardhan Anesthesiology National Institute of Neurological Disorders and Stroke 10/2020
Regulation of P-Body Formation and mRNA Decapping in Cancer: Control by AKT and Pim Kinase Phosphorylation of EDC3 Grant $394,690.00 Research Andrew Kraft Cancer Center Division National Cancer Institute 07/2020
Retrospective Independent Safety Review of Closed Irrisept Study Contract $42,700.00 Clinical Trial Andrew Tang Surgery IrriMax Corporation 10/2020
eNamptorTM: A Humanized mAb To Reduce the Severity of Radiation Pneumonitis and Fibrosis Grant $174,073.00 Research Anne Cress Cellular & Molecular Medicine Aqualung Therapeutics, Corp. 10/2020
Integrative Cancer Scholars Training Grant Grant $1,382,000.00 Research Training Anne Cress Cancer Center Division National Cancer Institute 10/2020
In Vivo Screening of Candidate Therapeutic Antibodies in Preclinical Models of Prostate Cancer Contract $31,231.00 Research Anne Cress Cellular & Molecular Medicine Aqualung Therapeutics, Corp. 02/2020
The Role of Ryanodine Receptors in Drug Seeking Grant $1,430,743.00 Research Arthur Riegel Pharmacology National Institute on Drug Abuse 02/2020
The MITRAL Trial (Mitral Implantation of TRAnscatheter VaLves is Native Mitral Stenosis) Contract $62,000.00 Clinical Trial Ashish Pershad COM Phx Internal Medicine Mayo Foundation for Medical Education and Research (Mayo Clinic) 01/2020
A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair with the Edwards PASCAL Transcatheter ...... Contract $141,792.00 Clinical Trial Ashish Pershad COM Phx Internal Medicine Edwards Lifesciences LLC 06/2020
Clinical Study of the BioVentrix Revivent TC System for Treatment of Left Ventricular Aneurysms Contract $194,732.72 Clinical Trial Ashish Pershad COM Phx Internal Medicine BioVentrix, Inc. 08/2020

Pages